Introduction to the launch time of Brivaracetam in China

Brivaracetam is a new anti-epileptic drug mainly used to treat partial-onset epilepsy, especially in patients who have not responded well to traditional anti-epileptic drugs. Brivaracetam regulates the release of neurotransmitters by highly selectively binding to synaptic vesicle protein SV2A, thereby stabilizing the electrical activity of neurons, reducing abnormal discharges and reducing the frequency of epileptic seizures. This mechanism of action enables it to show good safety and tolerability in multi-drug combination therapy, while causing less interference to the liver enzyme system and reducing the risk of drug interactions.

In the domestic market, the original drug of Brivaracetam has not yet been approved for marketing, which means that domestic patients are temporarily unable to purchase the original drug through formal channels. Due to the unmarketed status of the original drug, domestic hospital pharmacies and pharmacies are currently unable to provide the original version of Brivaracetam. For patients who want to use brivaracetam, they can usually only obtain it through overseas channels, or choose to wait for the launch of domestic generic drugs. According to overseas marketing experience, the original drug specification of Brivaracetam is usually 50mg*60 tablets, and the price per box is about more than 4,000 yuan. The price will fluctuate due to exchange rates, transportation costs and supply conditions. There are currently no generics of brivaracetam in the overseas market, making the original drug the only reliable treatment option.

It is worth noting that some domestic pharmaceutical companies have begun to develop generic drugs of Buvaracetam. The ingredients of these generic drugs are basically the same as the original version, and they have similar efficacy and safety. After generic drugs are launched, the cost of medication will be significantly reduced for patients, allowing more patients to benefit from the therapeutic advantages of brivaracetam. Regardless of whether it is an original drug or a generic drug, patients should formulate a dosage plan based on their personal condition and previous medication history under the guidance of a doctor before use.

In addition, attention needs to be paid to drug storage and medication safety during the use of brivaracetam. Medications should be placed in a dry, cool place, away from high temperatures and humid environments, and should be kept out of reach of children.

Reference materials:https://www.briviact.com/